The Australia and New Zealand diagnostic imaging services market is expected to see substantial growth over the next decade. With a projected CAGR of 6.34% from 2024 to 2032, the market expansion is driven by rising healthcare demands due to increased incidences of oncological, cardiovascular, and musculoskeletal disorders. This blog provides a detailed overview of […]
Global Chronic lower back pain Treatment Market remains one of the most prevalent conditions globally, affecting millions of individuals and causing significant discomfort, disability, and healthcare costs. As a growing concern, the global chronic lower back pain treatment market is projected to expand substantially in the coming years. According to recent estimates, the market size
The global clinical IT market has become a key area of growth in healthcare technology, valued at USD 7.55 billion in 2023. This expansion has been driven by an increased demand for remote patient monitoring (RPM) and telemedicine services, especially as healthcare providers seek more efficient, data-driven patient care solutions. With a compound annual growth
Global Clinical IT Market Share, Size, Trends, Growth, Outlook | 2024 – 2032 Read More »
The global idiopathic pulmonary fibrosis (IPF) treatment market, valued at USD 3.59 billion in 2023, is witnessing notable growth driven by several factors. Increased awareness, advancements in diagnostic technologies, and an aging population contribute significantly to the growing demand for IPF treatment. With the market projected to expand at a CAGR of 5.8% between 2024
The liver fibrosis market size was valued at USD 2,317.7 million in 2023, driven by the increasing incidence and awareness of liver fibrosis among people. The market size is anticipated to grow at a CAGR of 7.7% during the forecast period of 2024-2032 to achieve a value of USD 4,518.6 million by 2032. This substantial
The global medical wellness market size was valued at USD 1,492.37 billion in 2023, driven by the increasing geriatric population, coupled with the rising prevalence of diseases among these populations. The market is anticipated to grow at a CAGR of 14% during the forecast period 2024-2032 to reach a value of USD 4,853.12 billion by
